Monthly Archives June 2016

And the Molecule of the Year Award goes to…

Annually, Syncom grants the Molecule of the Year Award to the most profound of its many challenging research projects that are executed for its clients. The prize is a great recognition, acknowledging the creativity and stamina of the team of chemists that drove the project to a successful completion. This year the proud winners are Wolter ten Hoeve, Wouter van der Neut, Jochem van Herpt, Rory van der Hulst, Maxime Kraaijeveld, Belen Bazan, Lisette Bos-Slump and Jan Koek for their contribution in the route design, process R&D and successful scale up of a complex and promising novel API. “The existing
Read More

Eurostart Eureka European grant

Syncom has been awarded a grant for the development of novel enantiomerically pure functionalized polyhydroxyalkanoates (PHA’s). The resulting chiral 3-hydroxycarboxylic acids will be utilized as chiral synthons for fine chemistry (pharma) and as monomers in order to produce innovative homo-polymers and co-polymers for high-value markets. Syncom will seek for opportunities to use the chiral synthons in drug discovery and improved synthesis of new and existing drugs, including generics. In this project Syncom partners with Biopolis (Spain) and Polyvation (The Netherlands).  
Read More

Dutch Prime Minister Rutte visits Syncom BV

Yesterday, Syncom BV was honoured with the visit of Mark Rutte, the Prime Minister of the Netherlands. After opening the conference “Building the future of Health” at the UMCG, Mr. Rutte visited Innolab BV and Syncom BV in Groningen. Mr. Rutte was guided through one of Syncoms new and recently opened laboratories. He showed great interest in Syncoms activities for the pharmaceutical industry and spoke to several Syncom employees. Robert Hof, Chief Operating Officer of Syncom BV, commented: “Syncom is very proud Mr Rutte selected to visit Syncom BV, together with other innovative companies, as part of his tour in
Read More

BioBTX wins the Bio-Based Innovation Award 2016

Syncom proudly announces that our spin-off company BioBTX has been awarded with the Bio-Based Chemical Innovation Award. This prestigious prize acknowledges the importance of the research carried out by BioBTX to convert waste streams into valuable products with high efficiencies. Dr. Niels Schenk, Chief Technology Officer at  BioBTX said: “BioBTX has developed technology to convert crude glycerin from biodiesel production into key chemical building blocks such as para-xylene. With these chemical building blocks, it is possible to make performance materials out of biomass. We are very honored and proud that the international jury of independent industry experts selected us for
Read More